Forward Pharma (FWP) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Forward Pharma Reports Third Quarter 2015 Financial and Operational Results
November 25, 2015 7:30 AM ESTCOPENHAGEN, Denmark, Nov. 25, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP) ("We" or "Forward" or "Company"), today reported financial results for the third quarter ended September 30, 2015. Net loss for the third quarter ended September 30, 2015 was $15.8 million, or $0.34 per share versus $8.6 million, or $0.27 per share for the third quarter of 2014. On a non-GAAP basis, after removing the effect of non-cash income and expense items, our third quarter net loss for 2015 would have been $11.5 million, or $0.25 per share versus a net loss of $2.5 million or $0.08 per share for the third quarter of 2014.  As of September 30, 2015,... More



